Группа авторов

Nanotechnology in Medicine


Скачать книгу

      In the beginning of the twentieth century, Hermann Staudinger formulated the hypothesis of the existence of very large macromolecules with high molecular weights (Mülhaupt 2004). This hypothesis was verified experimentally in the 1920s, when Theodor Svedberg and Lawrence Bragg proved that hemoglobin and cellulose consisted in macromolecules (Rånby 1995). The acceptance of the existence of macromolecules allowed the development of a myriad of polymeric materials, such as plastics, rubbers, paints, and varnishes, that are now part of our daily lives. In addition to intentional discoveries, such as nylon, polyesters, and isotactic polypropylene, there were also accidental discoveries, such as polyethylene and polytetrafluoroethylene. Today, new and interesting macromolecules are being created to obtain new mechanical, optical, and electrical properties.

Schematic illustration of scheme of the productive chain of fossil-based polymers.

      Source: Based on Olivatto (2017).

      The advancement of nanotechnology for the design of several biotechnological devices such as nanoparticles, nanofilms, and liposomes based on natural polymers has gained great scientific importance due to their ecofriendly properties and biocompatibility with living systems. The nanotechnological devices based on natural polymers have been highlighted particularly in the development of pharmaceutical systems for drug delivery, tissue engineering, and bioactivation mechanisms. The low or no‐toxicity and safety of natural polymers are essential characteristics for the use of these nanodevices in health, as will be discussed in this chapter.

      In recent years, vegetable and microbial biopolymers have gained attention due to their versatility, ecofriendly characteristics, and the possibility of sustainable and large‐scale production. In addition to the environmental concern and the need to transition from the use of synthetic polymers to polymers from renewable resources, one must also consider geopolitical factors such as conflicts in the Middle East, Russia, and Venezuela, the main oil producers in the world (Mülhaupt 2012).

      In addition to biodegradability, a hot topic due to the appeal for sustainable development and responsible use of polymers, biopolymers have been increasingly used due to their low toxicity and good biocompatibility. Nanotechnology has taken advantage of such properties for the development of tools for environmental, food, pharmaceutical, and medical applications. As previously mentioned, petroleum‐based polymers are often chemically, physically, or biologically degraded into toxic compounds that may compromise the health of living organisms. In sequence, some examples of the toxicity of relevant synthetic polymers are presented.

       ε‐caprolactam (ε‐CAP) is a precursor of nylon‐6, widely used in industry for the production of carpets, clothing, and automotive equipment, systems, components, connectors, and as additive to plastic packaging. ε‐CAP waste can migrate from plastic packaging to food. Some toxicological studies indicate the possibility of ε‐CAP causing eye and skin inflammation, as well as irritation in the respiratory system. Hypotension, tachycardia, palpitations, rhinorrhea, nasal dryness, genitourinary, and reproductive effects such as disorders in menstrual and ovarian functions, and complications in childbirth may also occur, in addition to neurological and hematological problems (Bomfim et al. 2009);

       Epoxy polymers of bisphenol‐A diglycidyl ether (DGEBA) and aliphatic polyamine co‐monomers: triethylenetetramine (TETA), 1‐(2‐aminoethyl)piperazine (AEP) and isophorone diamine (IPD) had their interactions with biological systems tested in vitro. Although the results show that DGEBA‐IPD and DGEBA‐AEP are hemocompatible and polymers based on the IPD system are not considered cytotoxic, protein adsorption tests showed that the surface of the polymers adsorbs human albumin (González